Recent Finacing
Recent Raise
Biograil develops an injection-molded, standard-size oral capsule (BIONDD) using a non-mechanical, peristalsis-activated mechanism to deposit peptides and biomacromolecules into the gastrointestinal wall with biodegradable materials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
